DONATO, Rosario Francesco
 Distribuzione geografica
Continente #
NA - Nord America 12.307
EU - Europa 9.380
AS - Asia 8.568
SA - Sud America 1.666
AF - Africa 198
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 17
Totale 32.164
Nazione #
US - Stati Uniti d'America 12.069
SG - Singapore 3.923
UA - Ucraina 2.071
IE - Irlanda 1.359
BR - Brasile 1.332
HK - Hong Kong 1.227
CN - Cina 1.196
SE - Svezia 1.180
RU - Federazione Russa 1.143
IT - Italia 1.116
VN - Vietnam 707
DE - Germania 589
FR - Francia 482
KR - Corea 457
FI - Finlandia 444
GB - Regno Unito 346
IN - India 182
TR - Turchia 175
RO - Romania 126
AR - Argentina 122
BD - Bangladesh 122
CA - Canada 103
IQ - Iraq 102
PL - Polonia 85
CH - Svizzera 77
MX - Messico 70
AT - Austria 69
UZ - Uzbekistan 69
ZA - Sudafrica 66
NL - Olanda 58
PK - Pakistan 58
BE - Belgio 54
EC - Ecuador 53
CO - Colombia 50
JP - Giappone 46
ID - Indonesia 41
ES - Italia 35
SA - Arabia Saudita 35
PH - Filippine 31
LB - Libano 29
VE - Venezuela 29
CL - Cile 26
MA - Marocco 26
CZ - Repubblica Ceca 25
MY - Malesia 25
EU - Europa 23
GR - Grecia 21
JM - Giamaica 20
PY - Paraguay 20
KE - Kenya 18
SK - Slovacchia (Repubblica Slovacca) 17
TN - Tunisia 17
LT - Lituania 16
AZ - Azerbaigian 15
JO - Giordania 15
AE - Emirati Arabi Uniti 14
EG - Egitto 14
NP - Nepal 14
PE - Perù 14
AU - Australia 12
BG - Bulgaria 11
CR - Costa Rica 11
UY - Uruguay 11
ET - Etiopia 10
TH - Thailandia 10
AL - Albania 9
IL - Israele 8
KZ - Kazakistan 8
DZ - Algeria 7
MD - Moldavia 7
OM - Oman 7
BO - Bolivia 6
PS - Palestinian Territory 6
SN - Senegal 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GE - Georgia 5
PT - Portogallo 5
RS - Serbia 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
KH - Cambogia 4
KW - Kuwait 4
LV - Lettonia 4
MN - Mongolia 4
NI - Nicaragua 4
PA - Panama 4
TW - Taiwan 4
ZM - Zambia 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
IR - Iran 3
KG - Kirghizistan 3
NG - Nigeria 3
Totale 32.102
Città #
Singapore 2.845
Chandler 1.724
Dublin 1.358
Hong Kong 1.218
Jacksonville 1.140
San Jose 866
San Mateo 796
Ashburn 712
Boardman 563
Santa Clara 453
Moscow 447
Seoul 434
Wilmington 426
Medford 356
Princeton 353
Perugia 336
Lauterbourg 305
Ann Arbor 293
Dong Ket 245
Altamura 229
Beijing 228
Andover 202
Piscataway 184
Lawrence 172
Ho Chi Minh City 161
Los Angeles 146
São Paulo 122
Munich 121
New York 115
Saint Petersburg 115
Bucharest 111
Des Moines 104
The Dalles 100
Izmir 99
Helsinki 94
Hanoi 93
Dearborn 85
Shanghai 83
Norwalk 82
Redmond 70
Council Bluffs 67
Woodbridge 67
Falls Church 65
Brussels 53
Frankfurt am Main 51
Rio de Janeiro 48
Philadelphia 47
Dallas 45
Houston 42
Orem 42
Montreal 41
Rome 39
Baghdad 38
Tashkent 38
Vienna 38
Boston 36
Chennai 36
Tokyo 36
Chicago 34
Johannesburg 34
Shenzhen 34
Brooklyn 33
Milan 32
Warsaw 32
Auburn Hills 28
Da Nang 27
Stockholm 27
Belo Horizonte 26
Phoenix 26
London 25
Turku 25
Brasília 24
Lahore 24
Campinas 22
Guangzhou 22
Haiphong 22
Atlanta 21
Denver 21
Guayaquil 21
Manchester 21
Ankara 19
San Francisco 19
Den Haag 18
Falkenstein 18
Nairobi 18
Poplar 18
Bogotá 17
Columbus 17
Mexico City 17
Bratislava 16
Dhaka 16
Lausanne 16
Mumbai 16
Nuremberg 16
Porto Alegre 16
Quito 16
Redwood City 16
Baku 15
Istanbul 15
Nanning 15
Totale 19.330
Nome #
Le proteine S100 266
Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells 202
An HMGB1/RAGE/p38 MAPK/Myogenin Axis Modulates Pax7 Expression in Myoblasts by Both Transcriptional and Post-Transcriptional Mechanisms 178
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 173
Artesunate induces ROS-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells. 166
Annexins V and VI in skeletal muscle cells: relationships with the calcium-modulated proteins, S100A1 and S100B 165
Annexins V and VI in rat tissues during post-natal development: immunochemical measurements 163
Forced expression of S100B in a neuronal cell line (PC12) results in increased proliferation and reduced sensitivity to NGF 160
Analysis of S100A1, S100B and annexins V and VI in developing and adult avian skeletal muscles 156
Immunocytochemical detection of the calcium-regulated proteins, S100B and S100A1, in bovine retina: their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry 153
Oxidative stress-induced S100B accumulation converts myoblasts into brown adipocytes via an NF-κB/YY1/miR-133 axis and NF-κB/YY1/BMP-7 axis 151
Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes 149
RAGE in the pathophysiology of skeletal muscle. 147
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 147
Extracellular S100B causes nuclear translocation of NF-?B in rat L6 myoblasts likely by binding to RAGE 145
Differential expression of S100B protein and RAGE in young and aged human satellite cells. 144
Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces 143
Biological effects of astrocyte-derived S100-beta protein on BV-2 microglial cell line 142
Calcium- and protein kinase C-dependent association of S100A11 with S100B and vimentin intermediate filaments in LLC-PK1 renal cells 142
PP242 counteracts glioblastoma cell proliferation, migration, invasiveness and stemness properties by inhibiting mTORC2/AKT 141
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 140
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 138
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 138
Glucocorticoid-Induced Leucine Zipper (GILZ) and Long GILZ Inhibit Myogenic Differentiation and Mediate Anti-myogenic Effects of Glucocorticoids 136
A braking circuit between pathogen- and danger-sensing signaling pathways restrains lung inflammation: role of S100B protein, RAGE and Toll-like receptors. 136
The Pathophysiological Role of Microglia in Dynamic Surveillance, Phagocytosis and Structural Remodeling of the Developing CNS 136
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 136
Probing Internalization Effects and Biocompatibility of Ultrasmall Zirconium Metal-Organic Frameworks UiO-66 NP in U251 Glioblastoma Cancer Cells 136
Amphoterin-induced myogenic differentiation of RAGE-transfected rhabdomyosarcoma TE671 cells 135
Cellular and molecular mechanisms of sarcopenia: the S100B perspective 135
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 135
Activation of RAGE in myoblasts and rhabdomyosarcoma cells results in downregulation of Pax7 expression 133
RAGE signalling in myoblasts and embryonal rhabdomyosarcoma cells represses Pax7 expression via p38 MAPK-dependent induction of myogenin. 129
Annexin VI binds S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments 129
Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence 129
Aged vs young human satellite cells: altered expression of S100B and RAGE, and defective ability in conditioning the medium contribute to impaired myogenic potential. 128
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 128
S-100 proteins and microtubules: analysis of the effects of rat brain S-100 (S-100b) and ox brain S-l00ao, S-l00a and S-l00b on microtubule assembly-disassembly 127
Immunohistochemical localization of annexin V (CaBP33) in rat organs 126
S-100 protein binds to annexin II and p11, the heavy and light chains of calpactin I 126
Microglia-glioma cross-talk: a two way approach to new strategies against glioma 126
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 126
The calcium-modulated proteins, S100A1 and S100B, as potential regulators of the dynamics of the type III intermediate filaments 125
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 125
Annexin II2-p112 (calpactin I) stimulates the assembly of GFAP in a calcium- and pH-dependent manner. 125
Amphoterin stimulates myogenesis and counteracts the anti-myogenic factors, bFGF and S100B, via RAGE binding 124
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 124
Group II phospholipase A2 (GIIA) is involved in neuritogenesis in NGF-treated PC12 cells. 122
S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond 122
EFFECT OF NGF ON PHOSPHOLIPASES A2 LOCALIZATION IN PC12 CELLS 121
"Neuron-specific" protein gene product 9.5 (PGP 9.5) is also expressed in glioma cell lines and its expression depends on cellular growth 120
Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis 120
Interaction of annexins with S100 proteins. 119
Implication of RAGE and Amphoterin in Myogenesis 118
RAGE expression in rhabdomyosarcoma cells results in reduced proliferation, migration, and invasiveness in vitro and tumor growth in vivo 118
Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles 118
Different intrinsic properties of young and aged human satellite cells. 118
S-100 protein in cerebral cortex synaptosomes 116
Effect of NGF on the Subcellular Localization of Group IIA Secretory Phospholipase A2 (GIIA) in PC12 Cells: Role in Neuritogenesis. 116
Glial S100B protein in neuroprotection and neurodegeneration 115
Codistribution of S100A1 with synapsin I in discrete brain areas: S100A1 inhibits the F-actin bundling activity of synapsin I 114
Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization 114
Appropriate levels of extracellular S100B protein in injured muscle are required for correct muscle regeneration. 114
S100B protein in myoblasts modulates myogenic differentiation via NF-?B-dependent inhibition of MyoD expression. 113
Membrane-bound guanylate cyclase as the receptor of natriuretic peptides. A Minireview 113
S100B-mediated inhibition of the phosphorylation of GFAP is prevented by TRTK-12 112
S100B in myoblasts regulates the transition from activation to quiescence and from quiescence to activation, and reduces apoptosis 112
Immunocytochemical localization of annexin V (CaBP33), a Ca2+-dependent phospholipid- and membrane-binding protein, in the rat nervous system and skeletal muscles and in the porcine heart 111
Human S100B protein localizes to the nucleus in Nicotiana Tabacum 110
The Glucocorticoid-Induced Leucine Zipper (GILZ) inhibits skeletal myogenesis by counteracting MyoD activity 110
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 110
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 110
Riflessioni in merito al problema: Identikit dell’Anatomico, in “Tavola rotonda sull’Identità dell’Anatomia” 109
S100B retards the biochemical differentiation of myoblasts and their fusion into myotubes 109
Characterization of type III intermediate filament regulatory protein target epitopes: S100 (alpha and/or beta) binds the N-terminal head domain; annexin II2-p112 binds the rod domain 109
Association of S100B with intermediate filaments and microtubules in glial cells 109
NGF Induces the Expression of Group IIA Secretory Phospholipase A2 in PC12 Cells: The Newly Synthesized Enzyme Is Addressed to Growing Neurites 108
Cellular and subcellular distribution of secretory PLA2 in neural cells 107
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 107
S100B neuroprotective effect against ßamyloid-driven neurotoxicity 106
Synergistic regulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation 106
Calpactin I binds to the glial fibrillary acidic protein (GFAP) and to glial filaments in a Ca2+-dependent manner. Implications for concerted regulatory effects of calpactin I and S100 protein on glial filaments 106
Bovine annexin V isoforms: a molecular weight difference of 4 kDa by SDS-PAGE, 9 D by mass spectrometry 106
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 106
S100B inhibits myotube formation 105
Young and Aged Human Muscle Satellite Cells Show Differential Expression of S100B Protein and RAGE. 105
Immunocytochemical localization of S-100b protein in degenerating and regenerating rat sciatic nerves 105
S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner 105
Anti-myogenic activity of S100B in myoblasts 105
Role of calcium-binding proteins (S100B, annexin II2-p112, annexin VI) in the regulation of GFAP intermediate filament dynamics 105
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 105
Effects of S100B and S100A1 on cytoplasmic microtubules in triton-cytoskeletons from cell lines 104
RAGE engagement in myoblasts modulates proliferation, apoptosis, adhesiveness, migration and invasiveness 104
S100B in myoblasts inhibits myotube formation by interfering with MyoD 104
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 104
Chin Stimulation: A Trigger Point for Provoking Acute Hiccups 103
S100B protein in tissue development, repair and regeneration 103
Intracellular functions of S100B: S100B inhibits myoblast differentiation via stimulation of NF-kappaB transcriptional activity 102
Distribution of secretory phospholipase A2 (PLA2) in neural cells 102
Immunocytochemical localization of S-100b protein in olfactory and supporting cells of lamb olfactory epithelium 102
Totale 12.601
Categoria #
all - tutte 134.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 0 0 0 0 0 0 0 346
2021/20223.247 74 573 117 221 143 42 52 917 28 124 390 566
2022/20235.142 425 800 80 437 444 559 13 285 1.848 16 177 58
2023/20242.069 107 221 111 68 44 25 494 78 350 43 262 266
2024/20254.672 52 530 358 148 668 121 298 395 875 198 737 292
2025/202610.078 702 764 523 1.584 1.238 931 1.664 493 1.070 779 264 66
Totale 32.812